Understanding the double-edge sword of steroids

March 22, 2012, Flinders University

Glucocorticoids are a type of steroid hormone that are used to treat everything from asthma to arthritis, but the impact of these powerful anti-inflammatory drugs – particularly in prolonged, low-doses – remains to be fully understood.

Now researchers from Flinders University are on a mission to find out how long-term steroid treatment for and pituitary tumours affect the body’s metabolic and cardiovascular mechanisms.

Between half and one per cent of the country’s population take steroids, or about 1000 people in South Australia, with the over 50s the most common consumer.

“Research has already proven that high doses of steroids can cause diabetes, heart disease and weight gain but most patients are treated with low doses over a long period of time,” chief investigator Dr. Morton Burt (pictured), a senior lecturer in the School of Medicine, said.

“Yet there’s less evidence on the effects of low-dose steroid therapy,” he said.

“So what we want to know is whether steroids mainly reduce insulin production or make the body resistant to insulin.

“Without sufficient insulin the body can’t reduce glucose – and too much glucose in the blood causes diabetes.”

Dr. Burt’s preliminary studies have shown that therapeutic doses of steroids only increase blood glucose after eating. After eating most glucose is taken up into muscle. This suggests steroids may predominantly cause insulin resistance in muscle.

So far Dr. Burt has performed detailed metabolic studies on about a dozen people before and one week after commencing steroid treatment and has also studied a similar number who have been taking steroids for a long period of time.

“We give patients an injection of insulin to measure how much insulin they secrete over a 60 minute period,” Dr. Burt said.

“Subjects also have a six hour infusion of insulin and glucose to measure how resistant they are to and whether the resistance is in the liver or muscle or both.”

In another study, Dr. Burt is studying patients with pituitary tumours to determine what impact a higher or lower dose of steroids has on their risk of heart disease.

“For most of us, our blood vessels become more relaxed after eating but our hypothesis is that this will not happen in people who are using steroid therapy.”

Dr Burt, an endocrinologist at Southern Adelaide Diabetes and Endocrine Services, said the aim of his research is to develop new treatments that reduce the risk of heart disease in people who have steroid-induced diabetes.

are crucial in the treatment of many chronic diseases, yet they also have harmful side-effects. So if we can better understand these effects it will pave the way for therapies that specifically reverse the major metabolic abnormalities they induce – and reduce cardiovascular risk.”

Dr. Burt is supported by a South Australian Health Practitioner Fellowship and recently won a Flinders University’s 2011 Vice-Chancellor’s Awards for Early Career Researchers.

He and Dr. Elke Sokoya, a senior lecturer in human physiology in the School of Medicine, each have won $39,770 in research funding in the latest Diabetes Australia Research Trust Awards.

Explore further: Pressure to look more muscular may lead some men to consider steroids

Related Stories

Pressure to look more muscular may lead some men to consider steroids

June 3, 2011
Most people associate steroid use with oiled-up bodybuilders or professional athletes, but for some college-age men, steroids seem like the only way to measure up to the muscle-bound men in fitness magazines.

Well-controlled HIV doesn't affect heart metabolism, function

January 26, 2012
(Medical Xpress) -- People with HIV often develop blood sugar and lipid problems and other metabolic complications that increase the risk of heart disease. But new research at Washington University School of Medicine in St. ...

Scientists find missing link in regulation of glucose

December 22, 2011
(Medical Xpress) -- A team led by USC neuroscientist Alan Watts identified for the first time a biochemical signal that helps regulate the amount of glucose in the blood.

Could a drug reverse Type 2 diabetes?

September 23, 2011
Australian researchers have isolated a ‘master gene’ that controls Type 2 diabetes and say drugs that prevent or reverse the condition by switching off the gene may be as little as five years away

Researchers study biofeedback for asthma

November 22, 2011
National Jewish Health researchers are delving into the biology of biofeedback to understand how it helps asthma patients and what role it could play in reducing medication use for the chronic lung disease. In a study funded ...

Dieting beats exercise for diabetes prevention, combination is best

August 30, 2011
Lifestyle changes that include dieting to lose weight and exercise can help prevent type 2 diabetes, but researchers were uncertain which element contributes more. A new study suggests that, in postmenopausal women at least, ...

Recommended for you

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

Optimized human peptide found to be an effective antibacterial agent

January 11, 2018
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.